One Health Company Presents Groundbreaking Research at American Association for Cancer Research's Annual Meeting
FidoCure Blog
by Christina K. Lopes
1y ago
FOR IMMEDIATE RELEASE One Health Company Presents Groundbreaking Research at American Association for Cancer Research's Annual Meeting ORLANDO, FL (April 14, 2023) — The One Health Company, a leader in canine cancer genomics, will present the results from two studies at the American Association for Cancer Research's annual meeting in Orlando, Florida on Sunday, April 16. The research showcases One Health’s innovative use of real-world data from dogs with cancer to drive drug development strategies and inform human clinical trials. The first study, led by One Health’s Head of Veterinary Resear ..read more
Visit website
Get to know: Ben Toussant, Chief of Staff and Director of Strategic Operations, FidoCure®
FidoCure Blog
by Christina K. Lopes
1y ago
Tell us about your background. I grew up in Columbus, Ohio where my life revolved around playing sports and being outdoors – usually with my two brothers and the family dog. For my undergraduate education, I attended the Ohio State University where I played on the varsity baseball team and studied marketing. I think baseball really helped shape my approach to professional life – it instilled in me a high level of self discipline, a love of competition and a healthy understanding of the need for constant improvement. After graduating, I joined the United States Navy where I served as an intelli ..read more
Visit website
One Health Day: Scientific Advisory Board Recognition
FidoCure Blog
by Christina K. Lopes
1y ago
In 2017, Ben Lewis and Christina K. Lopes cofounded the One Health Company, based on this concept of working to attain optimal health for people and animals. Their first offering, FidoCure, introduced the therapies that have been successfully used to treat humans with cancer into the world of veterinary medicine. Like those mentioned in this quote, we assembled a board of key medical and veterinary advisors including multidisciplinary thinkers in the areas of canine and human oncology to help us positively impact the outcome for dogs with cancer. In recognition of One Health Day, we invite yo ..read more
Visit website
Veterinary Cancer Society 2022 Annual Conference Recap
FidoCure Blog
by Dr. Gerry Post
1y ago
This year’s Veterinary Cancer Society (VCS) annual meeting in Norfolk, VA was wonderful! First of all, seeing many of our friends and colleagues in person for the first time in two years was just amazing! I know that word gets used far too frequently, but in this case, I truly mean AMAZING--which according to the Merriam-Webster dictionary “causing astonishment, great wonder, or surprise”. All of these adjectives applied when I saw colleagues of over 30 years or residents from the past 20 years in person. Everyone I spoke with at VCS was so thankful and glad to be able to see so many of their ..read more
Visit website
Thrive Pet Healthcare and FidoCure® Announce An Expansive Pet Precision Health Partnership
FidoCure Blog
by Christina K. Lopes
1y ago
Strategic partnership leveraging FidoCure’s precision medicine platform advances joint vision for providing  personalized, accessible veterinary cancer care AUSTIN, TX and PALO ALTO, CA  — June, 2022 — Thrive Pet Healthcare, a national veterinary hospital network, and FidoCure, the leading pet precision health company, today announced a strategic partnership to provide personalized, accessible veterinary cancer care. Thrive Pet Healthcare’s nationwide network of over 350 veterinary care clinics will now have access to FidoCure’s cutting edge precision medicine platform and unparalle ..read more
Visit website
Get to Know: Chase Schwalbach, Chief Product Officer, FidoCure
FidoCure Blog
by Christina K. Lopes
2y ago
Tell us about your background I grew up on the Ohio/Kentucky border, from a relatively modest background. My mom worked 3 jobs to support me and my 2 siblings, and I didn’t step onto a plane until I graduated college. I went to school at Morehead State University in Kentucky and got an undergraduate degree in Finance. I feel so completely shocked at the type of work I get to do and the impact I get to make on the world, and I try to make the most of my chances every single day. In my career, I’ve went from Professional Poker Player to High Frequency Trading to the startup world, first working ..read more
Visit website
Get to Know: Michelle
FidoCure Blog
by Dr. Gerry Post
2y ago
Dr. Michelle White DVM, Ph.D, Head of Genomics, FidoCure What was your experience working with FidoCure® prior to joining the team? In my first virtual meeting with members of the FidoCure team, I was struck by how interested each member of the team seemed to be in understanding the approaches that the Karlsson Lab and others at the Broad Institute were using to analyze tumor genomes and troubleshoot problems that arose in the process. Their shared enthusiasm for the science and potential of precision medicine made the meeting both rewarding and fun. When I eventually met several members of t ..read more
Visit website
World Veterinary Day Interview: Strengthening Veterinary Resilience
FidoCure Blog
by Dr. Gerry Post
2y ago
Resilience is defined as the capacity to recover quickly from difficulties and toughness-- there are both physical and psychological resilience. Both have been severely tested these last few years with the pandemic, the current war, national divisions, etc. and have really affected veterinarians in the world at large. We are honored to share an interview featuring Dr .Mona Rosenberg, DVM Diplomate ACVIM (Oncology). In this candid and hopeful conversation, Chief Medical Officer Dr. Gerry Post talks with Mona about her definition of resilience and how she's incorporated the theme of never givin ..read more
Visit website
FidoCure® at VCS Mid-Year 2022: Lapatinib to treat grade II and III pulmonary carcinomas carrying ERBB2 V659E mutation: preliminary data
FidoCure Blog
by Dr. Lucas Rodrigues
2y ago
FidoCure® Data at VCS Mid-Year Abstract Presentation Review Rodrigues L, Girimonte D, Harvey G, Lambert L, Miller A, Hull A, Lewis B, Lopes C, Post G. Lapatinib to treat grade II and III pulmonary carcinomas carrying ERBB2 V659E mutation: preliminary data. In: Veterinary Cancer Society Mid- Year Conference: April 9-12, 2022; Puerto Vallarta, Mexico. In a nutshell During the Mid-Year Conference of the Veterinary Cancer Society held in Puerto Vallarta in April 2022, FidoCure® researchers presented data on the efficacy of lapatinib as adjuvant therapy for dogs with high grade (grade II and III ..read more
Visit website
Rising Women in Veterinary Oncology
FidoCure Blog
by Dr. Gerry Post
2y ago
An introduction from Chief Medical Officer, Dr. Gerry Post Veterinary medicine is changing. I remember one of my first days in veterinary school looking at the class pictures that were hung in the hallways. I remember seeing the first woman in one of these class photos and noting that she was still practicing. Indeed, over the past 30 years, the number of women entering veterinary medicine has grown substantially. I have witnessed that trend happening in veterinary oncology as well. But the numbers don’t tell the entire story. These women are making substantial progress and truly changing the ..read more
Visit website

Follow FidoCure Blog on FeedSpot

Continue with Google
Continue with Apple
OR